Fox Chase Cancer Center Geneticist Receives Nation's First Fellowship for Cancer Genetics Counseling
PHILADELPHIA (August 22, 2000) -- Anne Naumer, of Abington, Pa., a genetic counselor at Fox Chase Cancer Center, is the recipient of the nation's first post-graduate training fellowship dedicated to the new field of cancer genetics counseling. The William Randolph Hearst Fellowship in Cancer Genetics Counseling is a two-year rotating fellowship designed for candidates who have completed a master's level of education in the field.
The Hearst Fellowship was created through an endowment grant of $150,000 to Fox Chase from The William Randolph Hearst Foundation-one of the largest private foundations in the United States. Additional fund raising by Fox Chase, as part of the Prevention Campaign, brought the endowment to more than $500,000. Naumer receives a stipend from the endowment during her two-year appointment at Fox Chase.
Naumer, originally from Boulder, Colo., obtained her B.S. from the University of Colorado at Boulder with a dual major in biology and psychology in 1994. She received her master's degree from the graduate program in genetic counseling at the University of Colorado Health Sciences Center in 1999.
Naumer works in the Margaret Dyson Family Risk Assessment Program at Fox Chase under the direction of Dr. Mary B. Daly. In addition to offering training and mentorship in cancer genetics counseling, the fellowship requires that Naumer participate in and conduct genetic studies. So far, she has implemented collaborative research efforts with both the Dana-Farber Cancer Center in Boston and the James Cancer Center in Columbus, Ohio.
The nationally recognized Family Risk Assessment Program at Fox Chase is for women with a family history of breast and/or ovarian cancer. Developed by Daly, the goal is to help women learn more about risk factors associated with breast and ovarian cancer. Genetic counselors like Naumer work one-on-one with participants to provide up-to-date information on the familial patterns of these cancers and information on how pregnancy history, hormone use and diet may be related to breast or ovarian cancer.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at: www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.